← Back to news
NewsCLINICAL SCIENCE (LONDON, ENGLAND : 1979)Thursday, February 5, 2026 · February 5, 2026

Loss of ATF3 exacerbates pulmonary fibrosis via enhanced neutrophil recruitment and profibrotic macrophage polarization.

WHY IT MATTERS

Recent peer-reviewed research on Idiopathic pulmonary fibrosis that may be relevant for patients and caregivers.

Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease characterized by irreversible scarring, excessive extracellular matrix (ECM) deposition, and progressive loss of pulmonary function. Although innate immune cells, including neutrophils and macrophages, contribute to disea...

Read on PubMed
Read the original at Clinical science (London, England : 1979)
ResearchPubMedIdiopathic pulmonary fibrosisAnimalsActivating Transcription Factor 3

Related conditions

Idiopathic pulmonary fibrosis

Related news

Int J Circumpolar Health · -222 days ago
A population-based legacy study of myasthenia gravis in Iceland: insights from a small Arctic nation
Published in Int J Circumpolar Health. Hjaltason H et al.
Ther Adv Rare Dis · -192 days ago
Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy
Published in Ther Adv Rare Dis. Mitha A et al.
Health Inf Sci Syst · -192 days ago
PhenoRareAI: Phenotype-based intelligent diagnosis for rare neuromuscular disorders of glycogen storage disease and spinal muscular atrophy
Published in Health Inf Sci Syst. Zhai W et al.
J Allergy Clin Immunol Glob · -39 days ago
Emerging trends and research hot spots in inborn error of immunity: A bibliometric perspective
Published in J Allergy Clin Immunol Glob. Alblooshi H et al.